Release Details

PHOENIX, Oct. 20, 2026 /PRNewswire/ -- Trinity Capital Inc. (NYSE: TRIN) (the "Company"), a leading international alternative asset manager, today announced the commitment of $20 million in growth capital to ABM Respiratory Care (ABMRC), a medical technology company focused on developing and globally commercializing novel airway clearance and ventilation solutions.

ABMRC develops solutions for people with acute and chronic respiratory conditions. Its BiWaze^® platform, features technologies designed to support airway clearance, lung expansion, and secretion management across hospital and home care settings. The company also strives to advance connected care technologies to support patient engagement and provide care teams with greater visibility into respiratory therapy utilization.

"For patients with compromised respiratory systems, clearing the lungs and breathing comfortably takes real effort and the right technology. We believe ABM Respiratory Care builds that technology, and we are proud to support the team as they work to bring it to more patients around the world," said Rob Lake, Senior Managing Director, Healthcare & Life Sciences at Trinity Capital.

The financing will help ABMRC accelerate commercial expansion, strengthen its global market presence, and support continued investment in product innovation, clinical research, and connected respiratory care technologies.

"This financing represents another significant milestone in ABM Respiratory Care's growth and financial evolution," said Greg Miller, Chief Executive Officer of ABM Respiratory Care. "Building on our current strong commercial momentum, our partnership with Trinity Capital strengthens our financial foundation and provides the capital and operating flexibility to accelerate strategic growth initiatives, expand our presence in existing and new markets, and bring our innovative respiratory care technologies to more patients and healthcare providers worldwide."

About Trinity Capital Inc.
Trinity Capital Inc. (NYSE: TRIN) is an international alternative asset manager that seeks to deliver consistent returns for investors through access to private credit markets. Trinity Capital sources and structures investments in well-capitalized growth-oriented companies across five distinct lending verticals: Tech Lending, Equipment Finance, Healthcare & Life Sciences, Sponsor Finance, and Asset Based Lending. As a long-term, trusted partner for innovative companies seeking tailored debt solutions, Trinity Capital has deployed more than $6.2 billion across over 490 investments since inception in 2008 (as of June 30, 2026). Headquartered in Phoenix, Arizona, Trinity Capital's dedicated team is strategically located across the United States and Europe. For more information on Trinity Capital, please visit trinitycapital.com and stay connected to the latest activity via LinkedIn.

About ABM Respiratory Care
Founded in 2017, ABM Respiratory Care is dedicated to advancing patient care by developing intelligent, clinically differentiated respiratory care solutions to help people breathe better inside and outside the hospital. The company's connected platform is designed to improve respiratory therapy by promoting deeper breathing, enhancing oxygen exchange, reducing aerosol emission exposure, and enabling communication for better disease management across all care settings. For more information, visit www.abmrc.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/trinity-capital-inc-provides-20-million-in-growth-capital-to-abm-respiratory-care-to-advance-breathing-therapies-302913098.html

SOURCE Trinity Capital Inc.

Donnie Hogan, VP, Marketing Communications, Trinity Capital Inc., dhogan@trinitycapital.com; Leah Noaeill, VP of Marketing and Clinical, ABM Respiratory Care, Email: Leah.Noaeill@ABMRC.com